ArticleOncotarget2014

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.

Verena Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.